A meta-analysis by Zhang et al. 29 indicated that exon 19 deletion might be associated with longer PFS compared to L858 mutation at exon 21 after first-line EGFR-TKIs for patients with NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.